Aurinia Pharmaceuticals Inc (AUPH) — Cash Flow-to-Debt Ratio
Aurinia Pharmaceuticals Inc (AUPH) has a Cash Flow-to-Debt Ratio of 0.30x as of June 2026, meaning its operating cash flow of $52.57 Million could theoretically repay 0% of its total liabilities ($177.40 Million) in one year. See financial flexibility index of Aurinia Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Aurinia Pharmaceuticals Inc Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Aurinia Pharmaceuticals Inc across 28 annual periods. For the full cash flow conversion analysis, see Aurinia Pharmaceuticals Inc cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Aurinia Pharmaceuticals Inc (1998–2025)
Year-by-year debt coverage analysis for Aurinia Pharmaceuticals Inc. Check AUPH cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.80x | $135.66 Million | $170.26 Million | ▲ +210.8% |
| 2024 | 0.26x | $44.39 Million | $173.17 Million | ▲ +230.3% |
| 2023 | -0.20x | $-33.46 Million | $170.11 Million | ▲ +83.8% |
| 2022 | -1.22x | $-79.53 Million | $65.42 Million | ▲ +50.5% |
| 2021 | -2.45x | $-157.69 Million | $64.28 Million | ▼ -96.4% |
| 2020 | -1.25x | $-69.86 Million | $55.91 Million | ▲ +49.5% |
| 2019 | -2.47x | $-63.59 Million | $25.70 Million | ▼ -59.6% |
| 2018 | -1.55x | $-51.61 Million | $33.29 Million | ▲ +9.2% |
| 2017 | -1.71x | $-41.17 Million | $24.10 Million | ▼ -92.1% |
| 2016 | -0.89x | $-18.71 Million | $21.05 Million | ▲ +31.9% |
| 2015 | -1.31x | $-17.77 Million | $13.60 Million | ▲ +43.8% |
| 2014 | -2.32x | $-16.90 Million | $7.27 Million | ▼ -405.8% |
| 2013 | -0.46x | $-4.52 Million | $9.84 Million | ▲ +55.9% |
| 2012 | -1.04x | $-6.55 Million | $6.28 Million | ▼ -508.5% |
| 2011 | -0.17x | $-1.36 Million | $7.91 Million | ▲ +84.5% |
| 2010 | -1.10x | $-4.34 Million | $3.93 Million | ▲ +50.0% |
| 2009 | -2.21x | $-10.46 Million | $4.74 Million | ▼ -138.4% |
| 2008 | -0.93x | $-17.39 Million | $18.79 Million | ▲ +53.6% |
| 2007 | -2.00x | $-28.46 Million | $14.25 Million | ▲ +0.6% |
| 2006 | -2.01x | $-21.03 Million | $10.47 Million | ▼ -13.5% |
| 2005 | -1.77x | $-21.23 Million | $11.99 Million | ▲ +21.2% |
| 2004 | -2.25x | $-20.15 Million | $8.97 Million | ▼ -157.7% |
| 2003 | -0.87x | $-5.13 Million | $5.89 Million | ▼ -220.0% |
| 2002 | -0.27x | $-849.90K | $3.12 Million | ▲ +93.3% |
| 2001 | -4.07x | $-7.25 Million | $1.78 Million | ▲ +14.6% |
| 2000 | -4.77x | $-5.77 Million | $1.21 Million | ▼ -233.7% |
| 1999 | -1.43x | $-1.36 Million | $950.74K | ▼ -95.8% |
| 1998 | -0.73x | $-1.76 Million | $2.41 Million | — |